Hap Trading, LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 10, 2021	SELL	$74.77 - $85.47 $104,678 - $119,658	-1,400 Reduced 11.97%	10,300 $10,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $849,537 - $1.06 Million	11,700 New	11,700 $33,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $2.11 Million - $2.66 Million	-31,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $2.51 Million - $2.94 Million	31,300 New	31,300 $8,000
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $2.53 Million - $2.96 Million	-30,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$80.14 - $106.07 $2.4 Million - $3.18 Million	30,000 New	30,000 $1,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.